These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10228457)

  • 1. [Cytomegalovirus infection, a risk factor for acute graft rejection in renal transplant recipients. A case-controlled study].
    Bouedjoro-Camus MC; Novella JL; Toupance O; Wynckel A; Carquin J; Jolly D; Chanard J
    Presse Med; 1999 Mar; 28(12):619-24. PubMed ID: 10228457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus-related disease and risk of acute rejection in renal transplant recipients: a cohort study with case-control analyses.
    Toupance O; Bouedjoro-Camus MC; Carquin J; Novella JL; Lavaud S; Wynckel A; Jolly D; Chanard J
    Transpl Int; 2000; 13(6):413-9. PubMed ID: 11140239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus infection and graft rejection in renal transplantation.
    Dickenmann MJ; Cathomas G; Steiger J; Mihatsch MJ; Thiel G; Tamm M
    Transplantation; 2001 Mar; 71(6):764-7. PubMed ID: 11330539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of pretransplant cytomegalovirus infection on acute renal allograft rejection.
    Chen JH; Mao YY; He Q; Wu JY; Lv R
    Transplant Proc; 2005 Dec; 37(10):4203-7. PubMed ID: 16387078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus serostatus pairing and deceased donor kidney transplant outcomes in adult recipients with antiviral prophylaxis.
    Kuo HT; Ye X; Sampaio MS; Reddy P; Bunnapradist S
    Transplantation; 2010 Nov; 90(10):1091-8. PubMed ID: 20885340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.
    Varga M; Rajczy K; Telkes G; Hídvégi M; Péter A; Remport A; Korbonits M; Fazakas J; Toronyi E; Sárváry E; Kóbori L; Járay J
    Nephrol Dial Transplant; 2008 Aug; 23(8):2673-8. PubMed ID: 18332066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute rejection episodes in pediatric renal transplant recipients with cytomegalovirus infection.
    Kranz B; Vester U; Wingen AM; Nadalin S; Paul A; Broelsch CE; Hoyer PF
    Pediatr Transplant; 2008 Jun; 12(4):474-8. PubMed ID: 18466436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus infection after acute rejection therapy in seropositive kidney transplant recipients.
    Lee YM; Kim YH; Han DJ; Park SK; Park JS; Sung H; Hong HL; Kim T; Kim SH; Choi SH; Kim YS; Woo JH; Lee SO
    Transpl Infect Dis; 2014 Jun; 16(3):397-402. PubMed ID: 24810355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients.
    Sagedal S; Nordal KP; Hartmann A; Sund S; Scott H; Degré M; Foss A; Leivestad T; Osnes K; Fauchald P; Rollag H
    Am J Transplant; 2002 Oct; 2(9):850-6. PubMed ID: 12392291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical application of real time-polymerase chain reaction in determining cytomegalovirus viral DNA load in renal transplant recipients.
    Zhang CB; Lai HY; Xu HT; Wang DG; Xiao F
    Chin Med J (Engl); 2012 Oct; 125(19):3575-7. PubMed ID: 23044327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of HLA-G 14-bp polymorphism on acute rejection and cytomegalovirus infection in kidney transplant recipients from northwestern China.
    Jin ZK; Xu CX; Tian PX; Xue WJ; Ding XM; Zheng J; Ding CG; Ge GQ; Mao TC; Lin Y
    Transpl Immunol; 2012 Oct; 27(2-3):69-74. PubMed ID: 22750489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
    McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
    Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Low- Versus High-dose Valganciclovir for Prevention of Cytomegalovirus Disease in High-risk Renal Transplant Recipients.
    Gabardi S; Asipenko N; Fleming J; Lor K; McDevitt-Potter L; Mohammed A; Rogers C; Tichy EM; Weng R; Lee RA
    Transplantation; 2015 Jul; 99(7):1499-505. PubMed ID: 25643140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection.
    Reischig T; Jindra P; Svecová M; Kormunda S; Opatrný K; Treska V
    J Clin Virol; 2006 Jun; 36(2):146-51. PubMed ID: 16531113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of breakthrough infection among cytomegalovirus donor-positive/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis.
    Stevens DR; Sawinski D; Blumberg E; Galanakis N; Bloom RD; Trofe-Clark J
    Transpl Infect Dis; 2015 Apr; 17(2):163-73. PubMed ID: 25661673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus infection and disease following renal transplantation: preliminary report of incidence and potential risk factors.
    Taherimahmoudi M; Ahmadi H; Baradaran N; Montaser-Kouhsari L; Salem S; Mehrsai A; Kalantar E; Jahani Y; Pourmand G
    Transplant Proc; 2009 Sep; 41(7):2841-4. PubMed ID: 19765452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of cytomegalovirus disease in solid organ transplant recipients: a national matched cohort study in an inpatient setting.
    Hakimi Z; Aballéa S; Ferchichi S; Scharn M; Odeyemi IA; Toumi M; Saliba F
    Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28599091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus infection in renal transplant recipients: one center's experience.
    Bal Z; Uyar ME; Tutal E; Erdogan E; Colak T; Sezer S; Haberal M
    Transplant Proc; 2013; 45(10):3520-3. PubMed ID: 24314948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional profiles in urine during acute rejection, bacteriuria, CMV infection and stable graft function after renal transplantation.
    Øzbay A; Tørring C; Olsen R; Carstens J
    Scand J Immunol; 2009 Apr; 69(4):357-65. PubMed ID: 19284501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of cytomegalovirus infections and acute rejection episodes on the development of vascular changes in 6-month protocol biopsy specimens of cadaveric kidney allograft recipients.
    Helantera I; Koskinen P; Tornroth T; Loginov R; Gronhagen-Riska C; Lautenschlager I
    Transplantation; 2003 Jun; 75(11):1858-64. PubMed ID: 12811246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.